• Login
  • |
  • Register
RSS Feed Print
NGS and the patient electronic health record
Grant Wood
Posted: Thursday, August 25, 2011 5:11 PM
Joined: 4/25/2011
Posts: 2

We are entering into the genomic era of medicine, where a patient's genetic/genomic data is becoming important for clinical decision making, including disease risk assessment, disease diagnosis, drug therapy and dose selection, and risk assessment for adverse drug reaction.


Elecronic health record (EHR) systems need to be updated for the personalization of medicine, including receiving, storing, and using genetic/genomic data - combined with clinical and family health history data - for clinical decision support.


How will the advent of NGS affect initial efforts and future strategies of getting this data in, and used by, the EHR?

Eduardo Pareja
Posted: Saturday, August 27, 2011 2:52 AM
Joined: 2/16/2011
Posts: 4

With no doubt for me NGS data will enter very soon the clinical world and probably, the use of NGS at hospitals will be one of the main use of NGS.

One of the barriers for NGS data entering clinical institutions can be a lack of standards to interoperate. 

Grant Wood
Posted: Thursday, September 8, 2011 5:09 PM
Joined: 4/25/2011
Posts: 2

The HL7 Clinical Genomics workgroup (http://wiki.hl7.org/index.php?title=CG) is meeting in San Diego (Sep 12-16) to discuss and begin work on creating data standards for NGS. I will give a report here after the conference.
Gerald Higgins
Posted: Monday, May 28, 2012 8:02 PM
Joined: 3/7/2012
Posts: 2

I would also add that we are participating in the development of the interoperable electronic health record program for the Veteran's Administration and the DoD.


I would invite people to join the "genomics group" at http://www.osehra.org/group/genomics.


We also have a very loose advisory board that includes:


Gerry Higgins, (M.D.), Ph.D., AssureRx Health, CHAIR

Brian Athey, Ph.D., Academic CIO, University of Michigan Medical School, and Chair, Computational Medicine and Biomedical Informatics

Raith Erickson, Ph.D. Complete Genomics

Richard MacGuire, Ph.D. Genomics-Proteomics-Cell Translational Data, U.S. Healthcare, idbs

Dan Housman, Ph.D. CTO and Managing Director at Recombinant Data

Ken Kawamoto, M.D., Ph.D., co-director of the HL7 clinical decision support group and opencds.org (the Clinical Decision Support expert)

Christophe Lambert, Ph.D. CEO and President of Golden Helix

Julio Licinio, M.D., Director of the John Curtin School of Medical Research in Canberra, Australia

Dietrich Stephan, Ph.D., Co-Founder of Navigenics, T-GEN, Genia, Silicon Valley Biosystems


Please login to post a new topic or reply to an existing post.
Privacy Policy|Terms of Use